Multiple Sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Intervention 1: Intervention in the test group: The treatment program will held three sessions of motivational interviewing and each session for 90 minutes. Intervention 2: Intervention in the control
Intervention in the test group: The treatment program will held three sessions of motivational interviewing and each session for 90 minutes.
Intervention in the control group: the control group will participate in one session that will organize by researcher, and patients will discuss and share their experiences.
Sponsors
Isfahan University of Medical Sciences, School of Nursing and Midwifery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: a definite diagnosis of multiple sclerosis by a neurologist; points 0-5.5 expanded disability status scale (EDSS); absence of physical disease; absence of mental disease (DSM-IV-TR). Exclusion criteria: lack of desire to continue cooperation in research; lack of attendance at meetings (an absence of more than two sessions); to be hospitalized in hospital; the patient died before the end of the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-promoting behaviors. Timepoint: Before the intervention, 2 week after the intervention, 1 month after the intervention. Method of measurement: HPLPII questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Areas of Health-promoting behaviors. Timepoint: Before the intervention, 2 week after the intervention, 1 month after the intervention. Method of measurement: HPLPII questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactD.r Hojattolah Yousefi
Isfahan University of Medical Sciences, School of Nursing and Midwifery
Outcome results
None listed